{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T05:31:48Z","timestamp":1738819908813,"version":"3.37.0"},"reference-count":4,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:00:00Z","timestamp":1729123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jhepr.2024.101249","type":"journal-article","created":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T20:36:43Z","timestamp":1729370203000},"page":"101249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Understanding virologic heterogeneity in chronic hepatitis B treatment"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4318-7912","authenticated-orcid":false,"given":"Renqi","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Ran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5924-4389","authenticated-orcid":false,"given":"Ruihan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2024.101249_bib1","article-title":"Distinct virologic trajectories in chronic hepatitis B identify heterogeneity in response to nucleos\/tide analogue therapy","author":"Wang","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2024.101249_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29569","article-title":"Association of HBV serological markers with host antiviral immune response relevant hepatic inflammatory damage in chronic HBV infection","volume":"96","author":"Jiang","year":"2024","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.jhepr.2024.101249_bib3","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1007\/s00535-021-01826-8","article-title":"Effectiveness of tenofovir alafenamide for chronic hepatitis B patients with a poor response to the previously used nucleos (t) ide analogs","volume":"56","author":"Yamashige","year":"2021","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jhepr.2024.101249_bib4","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S1665-2681(19)31000-2","article-title":"Patient adherence to antiviral treatment for chronic hepatitis B and C: a systematic review","volume":"12","author":"Lieveld","year":"2013","journal-title":"Ann Hepatol"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555924002532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555924002532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:35:07Z","timestamp":1738802107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555924002532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":4,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2589555924002532"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2024.101249","relation":{},"ISSN":["2589-5559"],"issn-type":[{"type":"print","value":"2589-5559"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding virologic heterogeneity in chronic hepatitis B treatment","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2024.101249","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2024.101229","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101249"}}